Beryl Drugs share price
You have to be logged in to add this to Watchlist.- ₹23.85(-1.97%)April 13, 2026 15:17:39 PM IST
- NSE
- BSE
- Vol : 1.39 K (NSE + BSE)Last 20 day avg : 9.80 K
Beryl Drugs is trading -1.97% lower at Rs 23.85 as compared to its last closing price. Beryl Drugs has been trading in the price range of 23.85 & 23.36. Beryl Drugs has given 1.92% in this year & 26.46% in the last 5 days. Beryl Drugs has TTM P/E ratio 774.32 as compared to the sector P/E of 25.29.The company posted a net profit of -0.17 Crores in its last quarter.Listed peers of Beryl Drugs include Sun Pharmaceutical Industries (-0.16%), Divi's Laboratories (-1.01%), Torrent Pharmaceuticals (0.21%).The Mutual Fund holding in Beryl Drugs was at -% in . The MF holding has - from the last quarter. The FII holding in Beryl Drugs was at -% in . The FII holding has - from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Apr 14, 2026, 08:55 PM UTC
- BetaHigh volatility1.41Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.43The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values1.27The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values789.21Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation12.22The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | Bearish | 1,652.00 | -0.16 | 3,96,360.80 | 34.53 | 5.5 | 1.00 | 0.50 |
| Divi's Laboratories | Moderately Bearish | 6,057.50 | -1.01 | 1,61,192.52 | 74.01 | 10.85 | 0.49 | 0.01 |
| Torrent Pharmaceuticals | Bullish | 4,166.00 | 0.21 | 1,41,432.36 | 72.96 | 18.53 | 0.84 | 17.62 |
| Lupin | Bullish | 2,316.10 | -0.71 | 1,05,715.81 | 31.88 | 6.19 | 0.51 | 11.80 |
| Dr Reddy's Laboratories | Bearish | 1,235.00 | 0.24 | 1,03,092.01 | 18.13 | 3.06 | 0.65 | 2.34 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-04-01 | Notice of EGM & Others |
| 2026-02-09 | Quarterly Results |
| 2026-01-03 | Others |
| 2025-11-13 | Quarterly Results |
| 2025-09-02 | A.G.M. |
- IndustryBiotechnology & Drugs
- ISININE415H01017
- BSE Code524606
- NSE Code
Beryl Drugs is trading at 23.85 as on Mon Apr 13 2026 09:47:39. This is -1.97% lower as compared to its previous closing price of 24.33.
The market capitalization of Beryl Drugs is 12.10 Cr as on Mon Apr 13 2026 09:47:39.
The 52 wk high for Beryl Drugs is 30.00 whereas the 52 wk low is 15.92
Beryl Drugs can be analyzed on the following key metrics -
- TTM P/E: 774.32
- Sector P/E: 25.29
- Dividend Yield: 0.00%
- D/E ratio: -
Beryl Drugs reported a net profit of 0.58 Cr in 2025.